Ocular Therapeutix OCUL
NASDAQ OCUL
$7.66 -1.99 (-20.67%)
At close: Sep 28, 2026 · 4:00 PM EDT

Ocular Therapeutix (OCUL) Depreciation & Amortization (CF) (2013 - 2026)

Updated

Ocular Therapeutix's Depreciation & Amortization (CF) was $1.85 million in Q2 2026, up 80.4% from $1.03 million a year earlier and up 44.3% from the prior quarter.

Analysis

Ocular Therapeutix (OCUL) Depreciation & Amortization (CF) (2013 - 2026) Analysis & Trends

On a trailing twelve-month basis, Ocular Therapeutix's Depreciation & Amortization (CF) was $5.45 million through Jun 30, 2026, up 39.1% year-over-year; for FY2025, it was $4.32 million, up 14.2% from FY2024.

  • Depreciation & Amortization (CF) has now increased for three consecutive years, with a five-year compound annual growth rate of 9.3% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $3.79 million in FY2024 (+26.9%), $2.98 million in FY2023 (+41.4%), $2.11 million in FY2022 (-12.9%) and $2.42 million in FY2021 (-12.7%).
  • The Q2 2026 figure marks the highest quarterly Depreciation & Amortization (CF) in data going back to Q3 2013.
  • Compared with a year earlier, Depreciation & Amortization (CF) has increased for six straight quarters, with growth averaging 21.8% over the last eight quarters.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q4 2023 (growth of 95.1%); the worst was Q4 2021 (a decline of 14.5%).
  • Per Business Quant data, OCUL's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $1.28 million (Q1 2026), $1.25 million (Q4 2025) and $1.07 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 1.96 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 194.00 Mn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn -
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn 1.93 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 98.00 Mn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 56.50 Mn
10 Ocular Therapeutix 2.12 Bn 2.12 Bn 11.46 Mn 1.85 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.85 Mn
Mar 31, 2026 1.28 Mn
Dec 31, 2025 1.25 Mn
Sep 30, 2025 1.07 Mn
Jun 30, 2025 1.03 Mn
Mar 31, 2025 981,000.00
Dec 31, 2024 951,000.00
Sep 30, 2024 959,000.00
Jun 30, 2024 956,000.00
Mar 31, 2024 920,000.00
Dec 31, 2023 958,000.00
Sep 30, 2023 890,000.00
Jun 30, 2023 652,000.00
Mar 31, 2023 483,000.00
Dec 31, 2022 491,000.00
Sep 30, 2022 509,000.00
Jun 30, 2022 552,000.00
Mar 31, 2022 557,000.00
Dec 31, 2021 570,000.00
Sep 30, 2021 594,000.00
API Access

Ocular Therapeutix Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=OCUL&period=max&api_key=YOUR_API_KEY